Division of Gastroenterology, Hepatology, and Nutrition, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Center for Biostatistics, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Am J Gastroenterol. 2021 Sep 1;116(9):1938-1945. doi: 10.14309/ajg.0000000000001374.
Despite the increasing availability of advanced endoscopic resections and its favorable safety profile, surgery for nonmalignant colorectal polyps has continually increased. We sought to evaluate readmission rates and outcomes of elective surgery for nonmalignant colorectal polyps on a national level in the United States.
The Nationwide Readmissions Database (2010-2014 [International Classification of Diseases, Ninth Revision] and 2016-2018 [International Classification of Diseases, 10th Revision]) was used to identify all adult subjects (age ≥18 years) who underwent elective surgical resection of nonmalignant colorectal polyps. Multivariable analyses were performed for predictors of postoperative morbidity and 30-day readmission.
Elective surgery for nonmalignant colorectal polyps was performed in 108,468 subjects from 2010 to 2014 and in 54,956 subjects from 2016 to 2018, most of whom were laparoscopic. Postoperative morbidity and 30-day readmission rates were 20.5% and 8.5% from 2010 to 2014, and 13.0% and 7.6% from 2016 to 2018, respectively. Index admission mortality rates were 0.3-0.4%; mortality rates were higher in those with postoperative morbidity. Multivariable analyses revealed that male sex, ≥3 comorbidities, insurance status, and open surgery predicted an increased risk of both postoperative morbidity and 30-day readmission. In addition, postoperative morbidity (2010-2014 [odds ratio 1.58; 95% confidence interval 1.44-1.74] and 2016-2018 [odds ratio 1.55; 95% confidence interval 1.37-1.75]) predicted early readmission.
In this investigation of national practices, elective surgery for nonmalignant colorectal polyps remains common. There is considerable risk of adverse postoperative outcomes, which highlights the importance of increasing awareness of the range of endoscopic resections and referring subjects to expert endoscopy centers.
尽管先进的内镜下切除术的应用越来越广泛,且其安全性良好,但非恶性结直肠息肉的手术数量仍在持续增加。本研究旨在评估美国全国范围内非恶性结直肠息肉择期手术的再入院率和结局。
使用全国再入院数据库(2010-2014 年[国际疾病分类,第 9 版]和 2016-2018 年[国际疾病分类,第 10 版]),确定所有接受非恶性结直肠息肉择期手术切除的成年患者(年龄≥18 岁)。采用多变量分析评估术后并发症和 30 天再入院的预测因素。
2010 年至 2014 年,108468 例患者接受了非恶性结直肠息肉的择期手术,2016 年至 2018 年,54956 例患者接受了非恶性结直肠息肉的择期手术,其中大多数患者接受了腹腔镜手术。2010 年至 2014 年,术后并发症和 30 天再入院率分别为 20.5%和 8.5%,2016 年至 2018 年,分别为 13.0%和 7.6%。指数入院死亡率为 0.3%-0.4%;术后并发症患者的死亡率更高。多变量分析显示,男性、≥3 种合并症、保险状况和开放性手术增加了术后并发症和 30 天再入院的风险。此外,术后并发症(2010-2014 年[比值比 1.58;95%置信区间 1.44-1.74]和 2016-2018 年[比值比 1.55;95%置信区间 1.37-1.75])预测了早期再入院。
在这项全国性实践研究中,非恶性结直肠息肉的择期手术仍然很常见。术后不良结局的风险很大,这凸显了提高对内镜下切除术范围的认识并将患者转介至专家内镜中心的重要性。